These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15890718)

  • 1. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.
    Bouchillon SK; Johnson JL; Hoban DJ; Stevens TM; Johnson BM
    J Antimicrob Chemother; 2005 Jul; 56(1):224-7. PubMed ID: 15890718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
    J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
    Fuchs PC; Barry AL; Brown SD
    J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Banche G; Roana J; Allizond V; Andreotti S; Malabaila A; Li Vigni N; Mandras N; Scalas D; Tullio V; Carlone NA; Savoia D; Gaido E; Barbui A; Cuffini AM
    Lett Appl Microbiol; 2008 Oct; 47(4):309-14. PubMed ID: 19241525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
    De Vecchi E; Nicola L; Larosa M; Drago L
    BMC Microbiol; 2008 Jan; 8():23. PubMed ID: 18230154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001.
    Stratton CW; Brown SD
    Clin Ther; 2004 Apr; 26(4):522-30. PubMed ID: 15189749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae.
    Sato T; Kawai Y; Matsuda H; Tateda K; Kimura S; Ishii Y; Yamaguchi K; Gotoh N
    J Antimicrob Chemother; 2011 Jul; 66(7):1547-54. PubMed ID: 21511823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.
    Odenholt I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 2001 Jan; 45(1):23-9. PubMed ID: 11120939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of carbon dioxide on susceptibility testing of azithromycin, clarithromycin and roxithromycin against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes by broth microdilution and the Etest: Artemis Project-first-phase study.
    Johnson J; Bouchillon S; Pontani D
    Clin Microbiol Infect; 1999 Jun; 5(6):327-330. PubMed ID: 11856277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
    Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
    APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study].
    Gür D; Mülazimoğlu L; Unal S;
    Mikrobiyol Bul; 2007 Jan; 41(1):1-9. PubMed ID: 17427547
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Flamm RK; Rhomberg PR; Sader HS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
    Bogdanovich T; Bozdogan B; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CO(2) incubation on quinolone activity against Streptococcus pneumoniae and Haemophilus influenzae.
    Bolmstrom A; Karlsson A
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):65-9. PubMed ID: 11821174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.
    Stein GE; Schooley S; Tyrrell KL; Citron DM; Goldstein EJ
    Int J Antimicrob Agents; 2007 Jan; 29(1):39-43. PubMed ID: 17189093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
    Inoue M; Farrell DJ; Kaneko K; Akizawa K; Fujita S; Kaku M; Igari J; Yamaguchi K; Yamanaka K; Murase M; Asari S; Hirakata Y; Baba H; Itaha H
    Microb Drug Resist; 2008 Jun; 14(2):109-17. PubMed ID: 18500920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.